Limitations of Naloxone in Reversing Synthetic Opioid Overdoses

Naomi Carr
Hailey Okamoto
Written by Naomi Carr on 05 August 2026
Medically reviewed by Hailey Okamoto on 07 August 2026

Naloxone, an opioid antagonist, has proven to be a successful overdose antidote medication, saving many lives by reversing opioid effects. New research suggests that naloxone might have limitations, particularly in synthetic opioid overdose cases. However, naloxone remains the recommended and most effective accessible treatment for opioid overdoses and should always be used if an opioid overdose is suspected.

Limitations of Naloxone in Reversing Synthetic Opioid Overdoses

Why naloxone has been a cornerstone of overdose prevention

Opioid overdose deaths increased dramatically after 1999, mostly due to the surge in illegally produced synthetic opioids, such as fentanyl. The number of overdose deaths declined between 2022 and 2023, likely reflecting multiple factors, including expanded naloxone availability, greater access to medications for opioid use disorder, and broader harm reduction efforts.

Naloxone has substantially impacted opioid overdose outcomes as it can rapidly reverse the effects of opioids. Naloxone works by binding to opioid receptors and displacing opioid molecules from the mu-opioid receptor, rapidly reversing opioid-induced respiratory depression.

Naloxone is available as a nasal spray, which is very simple to use. This means that members of the public, with no medical training, can administer it to an individual during an opioid overdose, before medical professionals arrive on the scene.

With increasing availability and distribution of naloxone across the United States, this medication has successfully saved many lives.

What the 2026 study found

A new study published in Anesthesiology investigated the effect of naloxone in reversing opioid overdoses among two groups of participants: opioid-naïve individuals and people who use opioids daily. They utilized powerful synthetic opioids, fentanyl and sufentanil, in continuous infusions, to achieve a reduction in the participants’ breathing, simulating an overdose.

The participants were then administered a 4 mg dose of intranasal naloxone and monitored for their recovery. All participants’ breathing was restored within two to four minutes. However, among 18 of the 30 participants, carbon dioxide levels took 11 to 17 minutes to normalize, meaning that they remained at dangerous levels despite their breathing returning to normal.

These findings suggest that recovery may continue after breathing appears to improve, reinforcing the importance of continued monitoring after naloxone administration.

Why powerful synthetic opioids are harder to reverse

As this study demonstrates, naloxone can have a rapid and effective impact on the effects of an opioid overdose. However, synthetic opioids have unique chemical properties that vary from opium-based opioids like heroin. Because of this, synthetic opioid overdoses are often harder to reverse due to their speed of onset, potency, and duration of effects.

This can mean that:

  • The naloxone dose could wear off before the effects of the synthetic opioid have reduced. Once the impact of naloxone ends, the person may fall back into an overdose, as the opioid effects continue.
  • Compared to opioids like heroin and morphine, synthetic opioids like fentanyl can lead to a much faster onset of respiratory depression and other overdose effects. As such, the window for overdose reversal is significantly shortened, and the risks of fatal overdose are higher.

Although many fentanyl overdoses respond to standard naloxone doses, highly potent synthetic opioids may require repeated or higher cumulative doses to maintain reversal.

When multiple naloxone doses may be needed

Because of these variables, someone experiencing a synthetic opioid overdose might require multiple doses of naloxone to effectively reverse an overdose. This could involve several intranasal doses administered at regular intervals, as this can help to counteract the difference in effect duration.

Conversely, a person might require several intranasal doses administered in quick succession to provide a large enough dose to combat the synthetic opioid effects. Naloxone can also be administered via intramuscular (IM) or intravenous (IV) injection, which can increase the speed of delivery, particularly with IV administration, creating more rapid reversal effects.

Does this mean naloxone doesn’t work?

No, this does not mean that naloxone doesn’t work. Naloxone has been an effective and successful intervention for thousands of people. For example, one systematic review of community naloxone distribution success rates indicates 92.4-98.3% survival rates for people who have been administered naloxone during an overdose.

Similarly, nationwide data, compiled by the Centers for Disease Control (CDC), show approximately a 35% decrease in the number of overdose deaths from August 2023 to August 2025, thanks, in part, to a significant increase in naloxone availability.

What it does mean is that naloxone won’t work in the same way for every person or type of opioid. The administration method and dosage of naloxone might need to be different depending on the situation and type of opioid.

What to do during a suspected synthetic opioid overdose

If an opioid overdose of any kind is suspected, acting fast is crucial. Given the speed at which synthetic opioids act, it is imperative that professional medical help is sought urgently.

  1. Call 911.
  2. If it is available, immediately administer naloxone. Naloxone can be available to members of the public, people who use opioids illicitly or prescribed, and first responders, and it can be easily and rapidly administered during an overdose.
  3. While waiting for emergency response to arrive, place the individual in the recovery position or provide rescue breaths to prevent harm such as choking or respiratory depression.
  4. Monitor the individual continuously after the first naloxone dose has been administered. If, after a couple of minutes, the individual does not respond to the first naloxone dose, a second dose should be administered. This can be repeated several times if needed. Similarly, if the individual falls back into an overdose after the initial naloxone effects have worn off, an additional dose should be administered.
  5. If possible, it can be helpful to find out the type and dosage of the drug that has been used. It is important to be aware that this may not always be accurate, as many illegal substances contain contaminants and unknown doses. However, understanding the type and administration method of the drug can help to inform treatment, if the information is available.
  6. Remain with the person until professional medical assistance arrives.

How this research could change future overdose care

Synthetic opioids are incredibly dangerous, with dramatically higher potencies than opioids like heroin and morphine. Because of this, researchers are continuing to investigate how they are affected by naloxone and other opioid antagonists to develop the most effective overdose treatment for different types of opioids.

For example, this type of research has discovered that nalmefene, a more potent and faster-acting antagonist, can be more effective in synthetic opioid overdoses. However, because of its recent approval, it is currently less available than naloxone and costs significantly more. Additionally, it has the potential to cause the onset of dangerous withdrawal symptoms in those who use opioids chronically.

At present, naloxone remains the primary opioid antidote recommended by physicians, and further research into opioid overdose treatment is required.

Resources:

  1. Ahmad, F.B., Cisewski, J.A., Rossen, L.M., & Sutton, P. (2026). Provisional Drug Overdose Death Counts. CDC National Center for Health Statistics. Retrieved from
  2. National Institute on Drug Abuse. (2022). Naloxone Drug Facts. NIDA. Retrieved from
  3. van Lemmen, M.A., Florian, J., Li, Z., van Velzen, M., Olofsen, E., Dahan, A., Niesters, M., Sarton, E., & van der Schrier, R. (2026). Intranasal Naloxone Reversal of Opioid-induced Respiratory Depression in Opioid-naive Individuals and Self-reported Daily Opioid Users. Anesthesiology, 144(5), 1160–1172. Retrieved from
  4. Dahan, A., Franko, T.S., Carroll, J.W., Craig, D.S., Crow, C., Galinkin, J.L., Garrity, J.C., Peterson, J., & Rausch, D.B. (2024). Fact vs. Fiction: Naloxone in the Treatment of Opioid-Induced Respiratory Depression in the Current Era of Synthetic Opioids. Frontiers in Public Health, 12, 1346109. Retrieved from
  5. Skolnick, P., Paavola, J., & Heidbreder, C. (2024). Synthetic Opioids Have Disrupted Conventional Wisdom for Treating Opioid Overdose. Drug and Alcohol Dependence Reports, 12, 100268. Retrieved from
  6. Fischer, L.S., Asher, A., Stein, R., Becasen, J., Doreson, A., Mermin, J., Meltzer, M.I., & Edlin, B.R. (2025). Effectiveness of Naloxone Distribution in Community Settings to Reduce Opioid Overdose Deaths Among People Who Use Drugs: A Systematic Review and Meta-Analysis. BMC Public Health, 25(1), 1135. Retrieved from
  7. National Harm Reduction Coalition. (2024). Opioid Overdose Basics. NHRC. Retrieved from
  8. Stolbach, A.I., Mazer-Amirshahi, M.E., Nelson, L.S., & Cole, J.B. (2023). American College of Medical Toxicology and the American Academy of Clinical Toxicology Position Statement: Nalmefene Should Not Replace Naloxone as the Primary Opioid Antidote at this Time. Clinical Toxicology (Philadelphia, Pa.), 61(11), 952–955. Retrieved from

Activity History - Last updated: 07 August 2026, Published date:


Reviewer

Hailey Okamoto

M.Ed, LCMHCS, LCAS, CCS

Hailey Okamoto is a Licensed Clinical Mental Health Counselor, Licensed Clinical Addiction Specialist, and Certified Clinical Supervisor with extensive experience in counseling people with mental health and addictive disorders.

Activity History - Medically Reviewed on 05 August 2026 and last checked on 07 August 2026

Medically reviewed by
Hailey Okamoto

Hailey Okamoto

M.Ed, LCMHCS, LCAS, CCS

Reviewer

Recovered Branding BG
Ready to talk about treatment? Call today. (833) 840-1202
Helpline Information

Calls to numbers marked with (I) symbols will be answered or returned by one of the treatment providers listed in our Terms and Conditions, each of which is a paid advertiser.

In calling the helpline you agree to our Terms and Conditions. We do not receive any fee or commission dependent upon which treatment or provider a caller chooses.

There is no obligation to enter treatment.

Access State-Specific Provider Directories for detailed information on locating licensed service providers and recovery residences in your area.

For any specific questions please email us at info@recovered.org